Skip to main content
. 2020 Sep 2;11:2073. doi: 10.3389/fimmu.2020.02073

Table 4.

Characteristics of patients according to C4c deposition and/or C4 levels.

Variables Lower C4 level & no C4c deposition
(n = 29)
Lower C4 level & C4c deposition
(n = 11)
Higher C4 level & no C4c deposition
(n = 30)
Higher C4 level &
C4c deposition
(n = 9)
p-value
Clinical characteristics
Urinary protein (g/d) 2.74 (1.69, 4.88)a 2.68 (1.84, 11.51) 2.49 (1.77, 6.51)a 7.3 (6.04, 19.58) 0.006
eGFR
(ml/min/1.73 m2)
68 (39, 80.5) 52 (30, 89) 62 (37.75, 91.25) 41 (27, 68.5) 0.495
Scr (umol/L) 103.9 (92.35, 137.55) 122.4 (81.4, 209.2) 113.45 (86.48, 175.53) 158.7 (106.85, 219) 0.38
Pathological characteristics
Glomerular class (I/IIa/IIb/III/IV) 0/4/5/13/7 0/0/3/6/2 0/0/9/17/4 0/0/0/5/4 0.158
IFTA Score (0/1/2/3) 0/8/9/12 0/1/4/6 1/7/10/12 0/0/3/6 0.242
Interstitial inflammation score (0/1/2) 3/18/8a 0/5/6 1/19/10b 0/1/8 0.006
Vascular lesion Score (0/1/2) 14/8/7 2/6/3 9/11/10 5/2/2 0.352
Global sclerosis (%) 33.83 ± 28.32 36.69 ± 21.8 27.67 ± 26.74 38.97 ± 18.04 0.583

eGFR, estimated glomerular filtration rate; Scr, serum creatine; IFTA, interstitial fibrosis and tubular atrophy; C4, complement 4.

Continuous variables were presented as means ± standard deviation or medians (interquartile range), categorical variables as n (%). The p value with statistics significant (two-tailed p < 0.05) in the tables were marked bold. Other bold values were parameters for different classification.

a

Two-tailed p < 0.01 (compared to Higher C4 level & C4c deposition, post-hoc).

b

Two-tailed p < 0.05 (compared to Higher C4 level & C4c deposition, post-hoc).